Cefiderocol “under siege”? Understanding the rise of NDM-mediated resistance to novel agents
Chemical Science · 2025 · 16 (27) · 12519-12533
DOI: 10.1039/d5sc02122g ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Science, 2025. Verfasst von Brenda A Warecki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Universidad Nacional de Rosario Rosario Argentina vila@ibr-conicet.gov.ar. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: BLRD VA, NIAID NIH HHS, Agencia Santafesina de Ciencia, Tecnología e Innovación.
Abstract (Originalsprache)
The metallo-β-lactamase NDM is able to inactivate the last-generation antibiotic cefiderocol (FDC), in contrast to the related enzymes VIM and IMP. These results provide clues for the therapeutic use of FDC.
Autor:innen und Institutionen
- Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Universidad Nacional de Rosario Rosario Argentina vila@ibr-conicet.gov.ar.
- Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario Rosario Argentina.
- Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine Cleveland Ohio USA.
- CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland Ohio USA robert.bonomo@va.gov.
- Research Service, Veterans Affairs Northeast Ohio Healthcare System Cleveland Ohio USA.
- Laboratorio de Química Farmacéutica, Facultad de Química, Universidad de la República Montevideo Uruguay.
ORCID-Profile: Brenda A Warecki, Pablo E Tomatis, María F Mojica, Christopher R Bethel, Magdalena Rodríguez Saravia, Salvador I Drusin, Daisuke Ono, Guillermo Bahr, Krisztina Papp-Wallace, Pranita D Tamma, Diego M Moreno, Graciela Mahler, Robert A Bonomo, Alejandro J Vila
Förderung
- BLRD VA
- NIAID NIH HHS
- Agencia Santafesina de Ciencia, Tecnología e Innovación
- Division of Microbiology and Infectious Diseases
- Shionogi
- Fondo para la Investigación Científica y Tecnológica
- Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
- Biomedical Laboratory Research and Development, VA Office of Research and Development
Zitieren
APA
Warecki, B. A., Tomatis, P. E., Mojica, M. F., Bethel, C. R., Rodríguez Saravia, M., Drusin, S. I., Ono, D., Bahr, G., Papp-Wallace, K., Tamma, P. D., Moreno, D. M., Mahler, G., Bonomo, R. A., & Vila, A. J. (2025). Cefiderocol “under siege”? Understanding the rise of NDM-mediated resistance to novel agents. Chemical Science, 16(27), 12519-12533. https://doi.org/10.1039/d5sc02122g
Vancouver
Warecki BA, Tomatis PE, Mojica MF, Bethel CR, Rodríguez Saravia M, Drusin SI, et al. Cefiderocol “under siege”? Understanding the rise of NDM-mediated resistance to novel agents. Chemical Science. 2025;16(27):12519-12533. doi:10.1039/d5sc02122g
BibTeX
@article{Warecki2025,
author = {Warecki, Brenda A and Tomatis, Pablo E and Mojica, María F and Bethel, Christopher R and Rodríguez Saravia, Magdalena and Drusin, Salvador I and Ono, Daisuke and Bahr, Guillermo and Papp-Wallace, Krisztina and Tamma, Pranita D and Moreno, Diego M and Mahler, Graciela and Bonomo, Robert A and Vila, Alejandro J},
title = {Cefiderocol “under siege”? Understanding the rise of NDM-mediated resistance to novel agents},
journal = {Chemical Science},
year = {2025},
volume = {16},
number = {27},
pages = {12519--12533},
doi = {10.1039/d5sc02122g}
}
EUVIMED